Scilex Holding Company (Nasdaq: SCLX) Announces Effectiveness of Registration Statement on Form S-4 for the Proposed Business Combination of Denali Capital Acquisition Corp. and Semnur Pharmaceuticals, Inc., a Majority-Owned Subsidiary of Scilex
Denali Capital Acquisition Corp. Business Combination: The SEC has declared effective Denali's registration statement for a proposed business combination with Semnur Pharmaceuticals, scheduled for a shareholder vote on September 3, 2025.
Post-Closing Company Name Change: Upon completion of the business combination, the new entity will be renamed "Semnur Pharmaceuticals, Inc." and aims to list its common stock on Nasdaq, pending approval.
Trade with 70% Backtested Accuracy
Analyst Views on SCLXW
No data
About the author
SCILEX HOLDING CO - ACEA THERA TO ACQUIRE APPROXIMATELY 82% OF THE CONTINUING COMPANY AFTER CLOSURE
Company Overview: Cilex Holding Co. has a significant stake in the Go-Forward Company, owning approximately 82% of it.
Recent Developments: The ownership stake was confirmed upon the closing of a recent transaction.
SCILEX HOLDING CO - PHOENIX TO CHANGE NAME TO ACEA PHARMA, INC. AND PLANS TO DEBUT ON NASDAQ
- Company Name Change: SciLEx Holding Co. is set to be renamed as Acea Pharma, Inc.
- Upcoming Listing: The company is expected to list on the NASDAQ stock exchange.
SCILEX HOLDING CO - ACEA THERA TO DIVEST ENTIRE STAKE IN ACEA PHARMA TO PHOENIX FOR $1 BILLION IN STOCK
Acquisition Announcement: Cilex Holding Co. has announced the sale of its subsidiary, Acea, which includes 100% of the shares of Acea Pharma.
Transaction Value: The deal is valued at $1 billion, indicating a significant financial move in the pharmaceutical sector.
SCILEX HOLDING COMPANY REVEALS SUBSIDIARIES ACEA THERAPEUTICS, INC. AND ACEA PHARMA, INC. HAVE SIGNED A DEFINITIVE AGREEMENT WITH PHOENIX ASIA HOLDINGS LIMITED
Announcement of Agreement: SciLEx Holding Company has announced a definitive agreement with Phoenix Asia Holdings Limited.
Subsidiaries Involved: The agreement involves SciLEx's subsidiaries, Acea Therapeutics, Inc. and Acea Pharma, Inc.
SCILEX HOLDING CO PLANS TO LAUNCH DREAM BOWL TOKENS ON BICONOMY EXCHANGE
- Company Announcement: Cilex Holding Co. intends to list Dream Bowl tokens on the Biconomy exchange.
- Market Impact: This move is expected to enhance the visibility and trading opportunities for Dream Bowl tokens in the cryptocurrency market.
SCILEX HOLDING COMPANY DECLARES DIVIDEND OF DREAM BOWL I MEME COIN TOKENS FOR COMMON STOCKHOLDERS AND OTHER QUALIFIED EQUITY SECURITY HOLDERS, RECORD DATE SET FOR APRIL 30, 2026
- Dividend Announcement: Cilex Holding Company has announced a dividend of Dream Bowl Lime Meme Coin to holders of common stock and other eligible equity securities.
- Record Date: The record date for this dividend distribution is set for April 30, 2026.
SCILEX HOLDING CO - ACEA THERA TO ACQUIRE APPROXIMATELY 82% OF THE CONTINUING COMPANY AFTER CLOSURE
Company Overview: Cilex Holding Co. has a significant stake in the Go-Forward Company, owning approximately 82% of it.
Recent Developments: The ownership stake was confirmed upon the closing of a recent transaction.
SCILEX HOLDING CO - PHOENIX TO CHANGE NAME TO ACEA PHARMA, INC. AND PLANS TO DEBUT ON NASDAQ
- Company Name Change: SciLEx Holding Co. is set to be renamed as Acea Pharma, Inc.
- Upcoming Listing: The company is expected to list on the NASDAQ stock exchange.
SCILEX HOLDING CO - ACEA THERA TO DIVEST ENTIRE STAKE IN ACEA PHARMA TO PHOENIX FOR $1 BILLION IN STOCK
Acquisition Announcement: Cilex Holding Co. has announced the sale of its subsidiary, Acea, which includes 100% of the shares of Acea Pharma.
Transaction Value: The deal is valued at $1 billion, indicating a significant financial move in the pharmaceutical sector.
SCILEX HOLDING COMPANY REVEALS SUBSIDIARIES ACEA THERAPEUTICS, INC. AND ACEA PHARMA, INC. HAVE SIGNED A DEFINITIVE AGREEMENT WITH PHOENIX ASIA HOLDINGS LIMITED
Announcement of Agreement: SciLEx Holding Company has announced a definitive agreement with Phoenix Asia Holdings Limited.
Subsidiaries Involved: The agreement involves SciLEx's subsidiaries, Acea Therapeutics, Inc. and Acea Pharma, Inc.
SCILEX HOLDING CO PLANS TO LAUNCH DREAM BOWL TOKENS ON BICONOMY EXCHANGE
- Company Announcement: Cilex Holding Co. intends to list Dream Bowl tokens on the Biconomy exchange.
- Market Impact: This move is expected to enhance the visibility and trading opportunities for Dream Bowl tokens in the cryptocurrency market.
SCILEX HOLDING COMPANY DECLARES DIVIDEND OF DREAM BOWL I MEME COIN TOKENS FOR COMMON STOCKHOLDERS AND OTHER QUALIFIED EQUITY SECURITY HOLDERS, RECORD DATE SET FOR APRIL 30, 2026
- Dividend Announcement: Cilex Holding Company has announced a dividend of Dream Bowl Lime Meme Coin to holders of common stock and other eligible equity securities.
- Record Date: The record date for this dividend distribution is set for April 30, 2026.
